Klinische Notizen zu medizinischen Codes. KI-basiert. Kostenlos.

MedAPI.ai ist ein KI-gestützter Dienst für medizinisches Coding — per Websuche und REST-API. Gedeckte Vorschläge aus offiziellen Systematik-Inhalten, validiert gegen die autoritative Datenbank.

Codierungssysteme

Semantisches RAG-Retrieval, gedeckte Code-Vorschläge mit Confidence-Werten und Validierung gegen die autoritative Datenbank — über die unterstützten Codierungssysteme hinweg.

API

POST /api/code und GET /api/describe — Integration in KIS, Abrechnung und Forschung.

T42.8X5D

ICD-10-CM 2027 · Abrechenbar

Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter

Geschwistercodes

  • T42.8X5A – Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
  • T42.8X5S – Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela

Vererbt von T42.8: Poisoning by, adverse effect of and underdosing of antiparkinsonism drugs and other central muscle-tone depressants

Inclusion terms

  • Poisoning by, adverse effect of and underdosing of amantadine

Vererbt von T42: Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs

7th character

  • A = initial encounter
  • D = subsequent encounter
  • S = sequela

7th character note

  • The appropriate 7th character is to be added to each code from category T42

Excludes2

  • drug dependence and related mental and behavioral disorders due to psychoactive substance use (F10.--F19.-)

Teil von: T42.8X5: Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants › T42.8X: Poisoning by, adverse effect of and underdosing of antiparkinsonism drugs and other central muscle-tone depressants › T42.8: Poisoning by, adverse effect of and underdosing of antiparkinsonism drugs and other central muscle-tone depressants › T42: Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs